Who are (TauroLock Hep500)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Ethanol lock therapy (ELT), Normal Saline Catheter Lock Solution, Sodium Bicarbonate Catheter Lock Solution, Mino-Lok.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/taurolock-hep500.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

(TauroLock Hep500) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

(TauroLock Hep500) ((TauroLock Hep500)) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Catheter lock solution. Area: Infectious Disease / Vascular Access.

marketed Catheter lock solution Infectious Disease / Vascular Access Small molecule Live · refreshed every 30 min

Target snapshot

(TauroLock Hep500) ((TauroLock Hep500)) — Hamad Medical Corporation. TauroLock Hep500 is a catheter lock solution that prevents bacterial biofilm formation and thrombosis in central venous catheters through a combination of taurolidine and heparin.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
(TauroLock Hep500) TARGET	(TauroLock Hep500)	Hamad Medical Corporation	marketed	Catheter lock solution
Ethanol lock therapy (ELT)	Ethanol lock therapy (ELT)	Children's Hospital of Michigan	marketed	Antimicrobial catheter lock solution
Normal Saline Catheter Lock Solution	Normal Saline Catheter Lock Solution	Coney Island Hospital, Brooklyn, NY	marketed	Catheter lock solution
Sodium Bicarbonate Catheter Lock Solution	Sodium Bicarbonate Catheter Lock Solution	Coney Island Hospital, Brooklyn, NY	marketed	Catheter lock solution / antimicrobial lock therapy
Mino-Lok	Mino-Lok	Leonard-Meron Biosciences, Inc.	phase 3	Antimicrobial catheter lock solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Catheter lock solution class)

Coney Island Hospital, Brooklyn, NY · 1 drug in this class
Hamad Medical Corporation · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). (TauroLock Hep500) — Competitive Intelligence Brief. https://druglandscape.com/ci/taurolock-hep500. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab